Evidence map›Paper›PMID 25398328›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

CCAAT/enhancer-binding protein α negatively regulates IFN-γ expression in T cells.

Shinya Tanaka, Kentaro Tanaka, Fay Magnusson, Yeonseok Chung, Gustavo J Martinez, Yi-hong Wang, Roza I Nurieva, Tomohiro Kurosaki, Chen Dong

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.1field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. BCL6-dependent TCF-1Immunity · 2022
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Anti-inflammatory Activity of MTL-CEBPA, a Small Activating RNA Drug, in LPS-Stimulated Monocytes and Humanized Mice.Molecular therapy : the journal of the American Society of Gene Therapy · 2019
    Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Shinya TanakaDepartment of Immunology and Center for Inflammation and Cancer, MD Anderson Cancer Center, Houston, TX 77054; Laboratory of Lymphocyte Differentiation, World Premier International Immunology Frontier Research Center, Osaka University, Suita, Osaka 565-0871, Japan; and.
Kentaro TanakaDepartment of Immunology and Center for Inflammation and Cancer, MD Anderson Cancer Center, Houston, TX 77054;
Fay MagnussonDepartment of Immunology and Center for Inflammation and Cancer, MD Anderson Cancer Center, Houston, TX 77054;
Yeonseok ChungDepartment of Immunology and Center for Inflammation and Cancer, MD Anderson Cancer Center, Houston, TX 77054;
Gustavo J MartinezDepartment of Immunology and Center for Inflammation and Cancer, MD Anderson Cancer Center, Houston, TX 77054;
Yi-hong WangDepartment of Immunology and Center for Inflammation and Cancer, MD Anderson Cancer Center, Houston, TX 77054;
Roza I NurievaDepartment of Immunology and Center for Inflammation and Cancer, MD Anderson Cancer Center, Houston, TX 77054;
Tomohiro KurosakiLaboratory of Lymphocyte Differentiation, World Premier International Immunology Frontier Research Center, Osaka University, Suita, Osaka 565-0871, Japan; and.
Chen DongDepartment of Immunology and Center for Inflammation and Cancer, MD Anderson Cancer Center, Houston, TX 77054; Institute for Immunology, Tsinghua University, Beijing 100084, China chendong@tsinghua.edu.cn.
The University of Texas MD Anderson Cancer Center · USOsaka International University · JPOsaka University · JPTsinghua University · CN

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Effector and memory T follicular helper cellsR01AI106654 · NIAID · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DONG, CHEN · 2013 to 2015
$620k
NIAID NIH HHS R01 AI106654
6 · The paper itself

Abstract

Humoral immunity, including Ab switching and somatic hypermutation, is critically regulated by CD4(+) T cells. T follicular helper (Tfh) cells have been recently shown to be a distinct T cell subset important in germinal center reactions. The transcriptional regulation of Tfh cell development and function has not been well understood. In this study, we report that C/EBPα, a basic region/leucine zipper transcription factor, is highly expressed in Tfh cells. Cebpa-deficient CD4(+) T cells exhibit enhanced IFN-γ expression in vitro and in vivo. T cell-specific Cebpa knockout mice, although not defective in Tfh cell generation, produce significantly increased levels of IgG2a/b and IgG3 following immunization with a protein Ag. Moreover, C/EBPα binds to the Ifng gene and inhibits T-bet-driven Ifng transcription in a DNA binding-dependent manner. Our study thus demonstrates that C/EBPα restricts IFN-γ expression in T cells to allow proper class switching by B cells.

Indexed as

Gene Expression RegulationAnimalsB-LymphocytesCCAAT-Enhancer-Binding Protein-alphaCell DifferentiationGene Expression ProfilingImmunity, HumoralImmunoglobulin Class SwitchingImmunoglobulin GInterferon-gammaMiceMice, KnockoutT-bet Transcription FactorT-Box Domain ProteinsT-Lymphocytes, Helper-InducerT-Lymphocyte SubsetsCCAAT-Enhancer-Binding Protein-alphaIFNG protein, humanImmunoglobulin GInterferon-gammaT-bet Transcription FactorT-Box Domain Proteins

Identifiers

PMID25398328
PMCPMC4385522
OpenAlexW2146599257

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.